4//SEC Filing
SAPIRSTEIN JAMES 4
Accession 0001104659-23-001228
CIK 0001604191other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:00 AM ET
Size
5.1 KB
Accession
0001104659-23-001228
Insider Transaction Report
Form 4
SAPIRSTEIN JAMES
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Stock
2023-01-03+300,000→ 300,000 total
Footnotes (2)
- [F1]On January 3, 2023, the Reporting Person was granted 300,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023.
- [F2]Includes unvested RSUs.
Documents
Issuer
First Wave BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001559509
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:00 AM ET
- Size
- 5.1 KB